Fundraising Fox
/Companies
Sign in

Predicta Biosciences

Cambridge, US · Founded 2023 · 21 employees on LinkedIn · 2 known investors

Find your way into Predicta Biosciences

Sign up to see every warm intro you have to Predicta Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Predicta Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.

BiotechDigital HealthMedical Devices

Founders & leadership

Predicta Biosciences was founded in 2023 by Irene Ghobrial, Kenneth Anderson, Gad Getz, Romanos Sklavenitis-Pistofidis, and Keith Flaherty.

IGIrene Ghobrial
Irene GhobrialCo-founderIrene Ghobrial is a physician-scientist with expertise in multiple myeloma and Waldenström macroglobulinemia, including precursor conditions such as monoclonal gammopathy of undetermined significance and smoldering disease.
KAKenneth Anderson
Kenneth AndersonCo-founder
GGGad Getz
Gad GetzCo-founder
RSRomanos Sklavenitis-Pistofidis
Romanos Sklavenitis-PistofidisCo-founder
KFKeith Flaherty
Keith FlahertyCo-founder
BM
Brian McKernanCEOBrian McKernan is CEO of Predictabiosciences, a molecular diagnostics platform for blood cancer care. He previously served as CEO of Fluent BioSciences and co-founded multiple life sciences companies including Courtagen Life Sciences, Medicinal Genomics, and Agencourt Bioscience, with three exits; he holds an MBA in finance from Columbia Business School.

Investors · 2

The Engine Ventureslisted by The Engine VenturesCambridge

How we know: The Engine Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Related companies · 5

LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
PrecedePrecede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials. The platform enables non-invasive patient selection and longitudinal tracking of disease mechanisms in oncology and other therapeutic areas.
Predictive OncologyPredictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.
Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

Companies working in the same space as Predicta Biosciences.

Frequently asked questions

What does Predicta Biosciences do?
Predicta Biosciences operates a molecular insights platform for blood cancer care, using whole genome sequencing of intact circulating tumor cells from a single blood sample combined with single-cell immune profiling to characterize disease biology and immune response. Its diagnostics serve clinicians, researchers, and pharmaceutical partners working in hematological malignancies such as multiple myeloma.
Who founded Predicta Biosciences?
Predicta Biosciences was founded by Irene Ghobrial, Kenneth Anderson, Gad Getz, Romanos Sklavenitis-Pistofidis, Keith Flaherty in 2023.
Who are Predicta Biosciences's investors?
Predicta Biosciences's investors include Illumina Ventures, The Engine Ventures.
Where is Predicta Biosciences headquartered?
Predicta Biosciences is headquartered in Cambridge, US.